BONRAMP

BONRAMP is a high-potency bisphosphonate medication specifically used to treat and manage Osteoporosis, particularly in postmenopausal women, to reduce the risk of spine and hip fractures.

Each tablet contains Ibandronic Acid (also known as Ibandronate), a specialized pharmaceutical agent designed to regulate bone turnover.

It works by inhibiting the activity of osteoclasts, which are cells that break down bone tissue. By slowing down bone resorption, it allows bone-building cells (osteoblasts) to increase bone mineral density.

It is primarily indicated for postmenopausal women who are at a higher risk of bone thinning and fractures, though it may be prescribed for other bone-related metabolic conditions by a healthcare professional.

Unlike simple mineral supplements, BONRAMP is a prescription-grade therapy that actively alters the bone remodeling cycle to prevent the progressive bone loss associated with aging and hormonal changes.

Yes. To ensure proper absorption and prevent esophageal irritation, the tablet must be taken with a full glass of plain water on an empty stomach, usually 60 minutes before the first food or drink of the day.

No. Patients should remain upright (sitting, standing, or walking) for at least 60 minutes after taking the tablet to avoid the medication flowing back and irritating the esophagus.

Some patients may experience mild indigestion, heartburn, or muscle pain. Rare but serious side effects should be discussed with a doctor, especially regarding dental health or thigh bone pain.

Its high-potency formulation often allows for less frequent dosing (such as once monthly), making it easier for patients to stick to their treatment plan compared to daily medications.

It is manufactured by MK Healthcare in an ISO-GMP certified facility, adhering to the most stringent quality control protocols to ensure therapeutic purity and safety.